Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab
- PMID: 38756072
- DOI: 10.1093/mr/roae038
Successful treatment of systemic lupus erythematosus with residual disease activity by switching from belimumab to anifrolumab
Keywords: Anifrolumab; belimumab; biologics; systemic lupus erythematosus; treatment switching.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical